[Use of meropenem in the treatment of severe infections in newborns].
Meropenem was used in the treatment of 15 newborns (8 preterm) with sepsis, pneumonia or meningitis by intravenous infusion of 15-20 mg/kg daily divided to 3 equal doses. Clinical improvement was achieved in all the cases. No side effects were recorded.
Yatsyk
G V
GV
Research Institute of Pediatrics, Russian Academy of Medical Sciences, Moscow.
D001424:Bacterial Infections / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D016920:Meningitis, Bacterial / Q000188:drug therapy; D000077731:Meropenem; D018410:Pneumonia, Bacterial / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D013845:Thienamycins / Q000627:therapeutic use*
D013845:Thienamycins; D000077731:Meropenem
Ispol'zovanie meropenema v lechenii tiazhelykh infektsiĭ u novorozhdennykh deteĭ.